Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* CIS greater than or equal to 76, HADS less than or equal to 10~* ALT greater than upper limit of normal OR fatty liver on US~Exclusion Criteria:~* Subjects who have diseases that can cause fatigue~* Subjects who are taking medication that can cause fatigue

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- udca003 (Type: EXPERIMENTAL): udca003
- placebo (Type: PLACEBO_COMPARATOR): placebo of udca003

Based on this trial design, predict the completion outcome and termination type (if applicable).